Hyperthermic Radiochemotherapy for Esophageal Cancer – Rationale and Concept of a Phase III Trial

Publisher： Karger

E-ISSN： 2296-5262|22|1|48-52

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.22, Iss.1, 1999-03, pp. : 48-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preoperative Paclitaxel/Carboplatin Radiochemotherapy for Stage III/IV Resectable Oral and Oropharyngeal Cancer: Seven-Year Follow-Up of a Phase II Trial

By  

Oncology, Vol. 73, Iss. 3-4, 2008-04 ,pp. : 198-203

Karger

Access to resources Recommend Favorite

Fatal Herpes Simplex Virus Hepatitis in a Patient with Esophageal Cancer under Radiochemotherapy

By  

Oncology Research and Treatment, Vol. 31, Iss. 11, 2008-10 ,pp. : 620-622

Karger

Access to resources Recommend Favorite

Erlotinib and Radiation Therapy for Elderly Patients with Esophageal Cancer - Clinical and Correlative Results from a Prospective Multicenter Phase 2 Trial

By  

Oncology, Vol. 85, Iss. 1, 2013-07 ,pp. : 53-58

Karger

Access to resources Recommend Favorite

Concurrent Chemoradiotherapy with a Novel Fluoropyrimidine, S-1, and Cisplatin for Locally Advanced Esophageal Cancer: Long-Term Results of a Phase II Trial

By  

Oncology, Vol. 84, Iss. 6, 2013-05 ,pp. : 342-349

Karger

Access to resources Recommend Favorite

Economic analysis of a multicentre, randomised, phase III trial comparing FOLFOXIRI with FOLFIRI in patients with metastatic colorectal cancer in Greece

By Maniadakis N.   Pallis A.   Fragoulakis V.   Prezerakos P.   Georgoulias V.  

Current Medical Research and Opinion, Vol. 23, Iss. 9, 2007-09 ,pp. : 2251-2257

Informa Healthcare

Access to resources Recommend Favorite